Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · Real-Time Price · USD
2.750
+0.030 (1.10%)
Nov 21, 2024, 2:04 PM EST - Market open
Poseida Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 150.86 | 64.7 | 130.49 | 31.24 | - | - | Upgrade
|
| Revenue Growth (YoY) | 203.18% | -50.42% | 317.73% | - | - | - | Upgrade
|
| Cost of Revenue | 172.43 | 156.77 | 152.9 | 136.73 | 103.52 | - | Upgrade
|
| Gross Profit | -21.57 | -92.07 | -22.41 | -105.5 | -103.52 | - | Upgrade
|
| Selling, General & Admin | 40.93 | 37.44 | 37.54 | 35.92 | 23.03 | 18.46 | Upgrade
|
| Research & Development | - | - | - | - | - | 60.39 | Upgrade
|
| Operating Expenses | 40.93 | 37.44 | 37.54 | 35.92 | 23.03 | 78.85 | Upgrade
|
| Operating Income | -62.5 | -129.5 | -59.95 | -141.41 | -126.55 | -78.85 | Upgrade
|
| Interest Expense | -9.07 | -8.67 | -6.37 | -3.36 | -3.51 | -3.55 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 2 | Upgrade
|
| Other Non Operating Income (Expenses) | 10.86 | 14.85 | 2.86 | 19.8 | 0.28 | 0.56 | Upgrade
|
| EBT Excluding Unusual Items | -60.72 | -123.32 | -63.46 | -124.97 | -129.78 | -79.84 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -6.68 | Upgrade
|
| Pretax Income | -60.72 | -123.32 | -63.46 | -124.97 | -129.78 | -86.53 | Upgrade
|
| Income Tax Expense | 0.04 | 0.11 | 0.54 | - | - | - | Upgrade
|
| Net Income | -60.76 | -123.43 | -64 | -124.97 | -129.78 | -86.53 | Upgrade
|
| Net Income to Common | -60.76 | -123.43 | -64 | -124.97 | -129.78 | -86.53 | Upgrade
|
| Shares Outstanding (Basic) | 96 | 90 | 72 | 62 | 36 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 96 | 90 | 72 | 62 | 36 | 13 | Upgrade
|
| Shares Change (YoY) | 9.93% | 25.34% | 15.61% | 72.89% | 185.27% | 3.57% | Upgrade
|
| EPS (Basic) | -0.63 | -1.37 | -0.89 | -2.01 | -3.61 | -6.86 | Upgrade
|
| EPS (Diluted) | -0.64 | -1.37 | -0.89 | -2.01 | -3.61 | -6.86 | Upgrade
|
| Free Cash Flow | -17.13 | -95.23 | -30.7 | -105.18 | -130.24 | -69.67 | Upgrade
|
| Free Cash Flow Per Share | -0.18 | -1.06 | -0.43 | -1.69 | -3.62 | -5.52 | Upgrade
|
| Gross Margin | -14.30% | -142.29% | -17.17% | - | - | - | Upgrade
|
| Operating Margin | -41.43% | -200.15% | -45.94% | -452.69% | - | - | Upgrade
|
| Profit Margin | -40.28% | -190.76% | -49.05% | -400.07% | - | - | Upgrade
|
| Free Cash Flow Margin | -11.35% | -147.18% | -23.52% | -336.70% | - | - | Upgrade
|
| EBITDA | -57.02 | -123.89 | -54.77 | -136.86 | -123.96 | -77.66 | Upgrade
|
| EBITDA Margin | -37.80% | -191.47% | -41.97% | - | - | - | Upgrade
|
| D&A For EBITDA | 5.48 | 5.61 | 5.17 | 4.55 | 2.59 | 1.19 | Upgrade
|
| EBIT | -62.5 | -129.5 | -59.95 | -141.41 | -126.55 | -78.85 | Upgrade
|
| EBIT Margin | -41.43% | -200.15% | -45.94% | - | - | - | Upgrade
|
| Revenue as Reported | 150.86 | 64.7 | 130.49 | 31.24 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.